Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 18185536

Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Invest Dermatol
Publication date
2008 Jun
First author
Di Lorenzo G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Di Lorenzo G
      type
      Author
    2. name
      Kreuter A
      type
      Author
    3. name
      Di Trolio R
      type
      Author
    4. name
      Guarini A
      type
      Author
    5. name
      Romano C
      type
      Author
    6. name
      Montesarchio V
      type
      Author
    7. name
      Brockmeyer NH
      type
      Author
    8. name
      De Placido S
      type
      Author
    9. name
      Bower M
      type
      Author
    10. name
      Dezube BJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Di Lorenzo G
      type
      Author
    2. name
      Kreuter A
      type
      Author
    3. name
      Di Trolio R
      type
      Author
    4. name
      Guarini A
      type
      Author
    5. name
      Romano C
      type
      Author
    6. name
      Montesarchio V
      type
      Author
    7. name
      Brockmeyer NH
      type
      Author
    8. name
      De Placido S
      type
      Author
    9. name
      Bower M
      type
      Author
    10. name
      Dezube BJ
      type
      Author
    bibliography ids
    1. nci-bib-5c3d162e72a2eb97c93ae195
    book metadata
    content sha256
    4f0551165d625d9a89f7c8dd62f8f09419978867591c3d594c8254883fab4432
    document type
    citation
    dois
    1. 10.1038/sj.jid.5701215
    electronic publication date
    display
    2008 Jan 10
    precision
    day
    year
    2008
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:18185536
    immutable id
    pubmed:18185536@4f0551165d625d9a89f7c8dd62f8f09419978867591c3d594c8254883fab4432
    journal
    abbreviation
    J Invest Dermatol
    issn electronic
    1523-1747
    issn print
    0022-202X
    issue
    6
    name
    The Journal of investigative dermatology
    nlm unique id
    0426720
    pages
    1578-80
    volume
    128
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      18185536
      provenance
      batch id
      89a0f2206e11ca092d02
      provider
      NCBI PubMed ESummary
      record sha256
      5f2a918956a76b3020b83da224af2bdcf961687a0042c44108d654d9d6aa3df0
      response sha256
      7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
      retrieved at
      2026-09-09T23:46:16.784581+00:00
      publication date
      display
      2008 Jun
      precision
      month
      year
      2008
      publication types
      1. Letter
      2. Multicenter Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/18185536/
      title
      Activity and safety of pegylated liposomal doxorubicin as first-line therapy in the treatment of non-visceral classic Kaposi's sarcoma: a multicenter study.

      Preserved source evidence · Not medical advice